Gevo, Inc. (GEVO) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of Gevo, Inc. (NASDAQ:GEVO) from a hold rating to a buy rating in a research note released on Tuesday, August 8th. The brokerage currently has $0.75 price objective on the energy company’s stock.

According to Zacks, “Gevo, Inc. is a renewable chemicals and advanced biofuels company engaged in the development of biobased alternatives to petroleum-based products using a combination of synthetic biology and chemistry. The Company is focused on the commercialization of isobutanol, a naturally occurring four carbon alcohol with broad applications in large chemicals and fuels markets. Isobutanol can be used as a solvent and a gasoline blendstock and can be further processed into jet fuel and feedstocks for the production of synthetic rubber, plastics and polyesters. Markets served by the Company include solvents and coatings, materials, plastics and fibers, biojet blendstock, gasoline blendstock and other hydrocarbon fuels. “

Separately, HC Wainwright set a $12.00 price objective on shares of Gevo and gave the stock a buy rating in a research note on Wednesday, July 26th.

Shares of Gevo (NASDAQ GEVO) traded down 0.174% during trading on Tuesday, hitting $0.574. 385,290 shares of the stock traded hands. Gevo has a 52-week low of $0.53 and a 52-week high of $15.97. The company’s 50 day moving average is $0.62 and its 200 day moving average is $1.00. The firm’s market cap is $9.31 million.

Gevo (NASDAQ:GEVO) last released its quarterly earnings data on Thursday, August 3rd. The energy company reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.54) by $0.10. Gevo had a negative net margin of 108.86% and a negative return on equity of 35.92%. The company had revenue of $7.54 million during the quarter, compared to the consensus estimate of $5.63 million. On average, equities research analysts predict that Gevo will post ($2.94) EPS for the current year.

WARNING: “Gevo, Inc. (GEVO) Upgraded by Zacks Investment Research to Buy” was originally posted by BBNS and is owned by of BBNS. If you are accessing this piece on another publication, it was stolen and republished in violation of United States & international trademark and copyright laws. The correct version of this piece can be read at https://baseballnewssource.com/markets/gevo-inc-gevo-upgraded-by-zacks-investment-research-to-buy-updated/1410289.html.

Several hedge funds and other institutional investors have recently bought and sold shares of GEVO. Virtu KCG Holdings LLC boosted its position in Gevo by 557.6% in the second quarter. Virtu KCG Holdings LLC now owns 182,390 shares of the energy company’s stock worth $126,000 after buying an additional 154,654 shares during the last quarter. Vanguard Group Inc. boosted its position in Gevo by 22.4% in the second quarter. Vanguard Group Inc. now owns 486,959 shares of the energy company’s stock worth $336,000 after buying an additional 89,020 shares during the last quarter. Finally, Sabby Management LLC purchased a new position in Gevo during the first quarter worth approximately $1,274,000. 14.84% of the stock is currently owned by institutional investors and hedge funds.

Gevo Company Profile

Gevo, Inc (Gevo) is a renewable chemicals and next generation biofuels company. The Company has developed a technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstock.

Get a free copy of the Zacks research report on Gevo (GEVO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Gevo Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Kris Bryant Back in Spotlight, Cubs Pushing for Playoff Berth
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Changes to Reduce The Length of Games, MLB Games are Actually Getting Longer
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Despite Hitting Home Run, Judge Sets Longest Game Streak for Strikeouts
Los Angeles Dodgers Move 50 Games Over .500
Los Angeles Dodgers Move 50 Games Over .500
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Miami’s Giancarlo Stanton Sets Marlins Home Run Record
Bryce Harper Latest Star to Suffer Injury
Bryce Harper Latest Star to Suffer Injury


Leave a Reply

 
© 2006-2017 BBNS.